1Alikhan R, Cohen AT (2009) Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev.

2Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 146:278-288.

3Collins R, Scrimgeour A, Yusuf S, Peto R (1998) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 318:1162-1173.

4Amin AN, Varker H, Princic N, Lin J, Thompson S, Johnston S (2012) Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients. J Hosp Med 7:231-238.

5Samama M-M (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160:3415-3420.

6Samama MM, Dahl OE, Quinlan DJ, Mismetti P, Rosencher N (2003) Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool. Haematologica. 88:1410-1421.

7Hull RD, Schellong SM, Tapson VF (2010) Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial 153: 8-18.

8Alexander T. Cohen MD, Theodore E, et al. (2013) Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients. 368:513-523.

9Samuel Z. Goldhaber M.D, Alain Leizorovicz M.D, Ajay K. Kakkar M.D, et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.